Vaxcyte, Inc.
PCVX
$30.66
-$1.63-5.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.66B | 1.67B | 1.75B | 2.18B | 1.45B |
| Total Receivables | 100.00K | -- | 20.66M | 17.87M | 17.88M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.25M | 44.83M | 15.73M | 10.59M | 9.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 4.38M | 4.94M | 1.72M |
| Total Current Assets | 1.72B | 1.72B | 1.79B | 2.21B | 1.48B |
|
|
|||||
| Total Current Assets | 1.72B | 1.72B | 1.79B | 2.21B | 1.48B |
| Net Property, Plant & Equipment | 327.92M | 304.91M | 270.15M | 191.94M | 152.75M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 96.58M | 77.60M | 65.68M | 61.36M | 53.79M |
| Total Assets | 3.31B | 3.38B | 3.51B | 3.56B | 2.09B |
|
|
|||||
| Total Accounts Payable | 31.41M | 20.51M | 48.45M | 18.22M | 10.47M |
| Total Accrued Expenses | 116.77M | 70.35M | 85.84M | 95.93M | 65.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.30M | 6.13M | 5.89M | 9.64M | 7.29M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 154.49M | 97.00M | 140.18M | 123.79M | 82.85M |
|
|
|||||
| Total Current Liabilities | 154.49M | 97.00M | 140.18M | 123.79M | 82.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 79.54M | 81.08M | 65.22M | 18.32M | 18.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 100.00K | -- | -- |
| Total Liabilities | 234.03M | 178.08M | 205.50M | 142.11M | 101.14M |
|
|
|||||
| Common Stock & APIC | 4.77B | 4.73B | 4.70B | 4.67B | 3.13B |
| Retained Earnings | -1.70B | -1.53B | -1.39B | -1.25B | -1.15B |
| Treasury Stock & Other | -1.89M | -322.00K | -3.87M | 139.00K | 1.82M |
| Total Common Equity | 3.07B | 3.20B | 3.31B | 3.42B | 1.99B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.07B | 3.20B | 3.31B | 3.42B | 1.99B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.07B | 3.20B | 3.31B | 3.42B | 1.99B |
|
|
|||||